Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Paul Lyon

BSc, MSc, MRes, BMBS, MRCS, DPhil

Clinical Research Fellow

  • High Intensity Focused Ultrasound (HIFU) Fellow
  • Keble College Tutor (2014-2015)
  • Academic Clinical Fellow in Radiology

I am currently in post as an Academic Clinical Fellow in Radiology. This follows time in research as a NIHR-funded Clinical Research Fellow studying for a DPhil in targeted drug delivery. More specifically, my research concerns the use of focused ultrasound (HIFU) for targeted drug delivery and its clinical translation. I am involved in conducting a Phase I clinical trial, which aims to demonstrate the feasibility of using a clinical HIFU device in combination with a thermo-sensitive drug delivery system to deliver targeted chemotherapy to cancer patients with liver tumours (TARDOX study, NCT02181075). The study is multidisciplinary and I have been involved in many aspects including trial design, ethics and trial management, analytical laboratory techniques, use of focused ultrasound for hyperthermia and radiological imaging, with the world-class research facilities and expertise available within the University of Oxford and Oxford University Hospitals NHS Trust.

This study has the potential for significant clinical impact as, if feasibility of targeted drug delivery using this modality can be successfully demonstrated for liver tumours, following further clinical trials, non-invasive targeted therapy using tailored chemotherapeutics for a variety of solid organ cancers could become a reality.